Species in the genus Bacteroides carry out broad metabolic functions, including degradation of complex plant polysaccharides, proteolytic activities, de-conjugation of bile acids, mucosal barrier integrity, short chain fatty acid production, fatty acid storage and glucose metabolism. Bacteroides spp. are maintained at a higher abundance in breastfed individuals into adulthood. Bacteroides fragilis plays an important role in the prevention of intestinal inflammation. An energy-restricted diet has been shown to increase B. fragilis in overweight adolescents. An increase in B. stercoris has been associated with higher risk of colon cancer. Decreased levels of Bacteroides spp. have been reported in association with multiple sclerosis, rheumatoid arthritis and Parkinson’s disease.

The Bacteroidetes Phylum marker refers to a group of bacteria commonly found in the human gut, playing a crucial role in the digestive process. This phylum includes various species that are essential for breaking down complex molecules like carbohydrates and fibers, helping in the absorption of nutrients and the production of short-chain fatty acids which are vital for gut health. The presence and balance of Bacteroidetes can be an indicator of gut flora health; for instance, a healthy balance between Bacteroidetes and another major gut bacteria group, Firmicutes, is often associated with good digestive health. On a GI panel, the levels of Bacteroidetes are assessed to help diagnose potential issues such as dysbiosis, where there is an imbalance in gut microbial communities. This can be linked to various health conditions, including obesity, diabetes, and inflammatory bowel diseases. By monitoring Bacteroidetes levels, healthcare providers can gain insights into a patient’s gut health, which can inform dietary recommendations and treatment plans aimed at restoring gut flora balance and improving overall health.